Krystal Biotech Q3 EPS $2.05 Beats $1.77 Estimate, Sales $127.341M Beat $126.079M Estimate
Benzinga Newsdesk 6 hours ago
NewsEarningsEarnings Beats
Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $2.05 per share which beat the analyst consensus estimate of $1.77 by 15.82 percent. This is a 22.93 percent decrease over earnings of $2.66 per share from
Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $2.05 per share which beat the analyst consensus estimate of $1.77 by 15.82 percent. This is a 22.93 percent decrease over earnings of $2.66 per share from the same period last year. The company reported quarterly sales of $127.341 million which beat the analyst consensus estimate of $126.079 million by 1.00 percent. This is a 30.21 percent increase over sales of $97.800 million the same period last year.